Report of Foreign Issuer (6-k)
March 05 2018 - 9:51AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
W
ashington,
D.C.
20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
For the month of March 2018
Commission File Number: 001-37643
KITOV PHARMA
LTD.
(Translation of registrant's name into English)
One
Azrieli Center, Round Tower,
Tel
Aviv 6701101, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
On March 5, 2018, Kitov Pharma Ltd. (the “Company”
or the “Registrant”) issued a press release, “
Kitov Pharmaceuticals Publishes Annual Report for 2017 and Issues
CEO Letter to Shareholders
”, which is attached hereto as Exhibit 99.1
Attached hereto are the following exhibits:
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
KITOV PHARMA LTD.
|
|
|
March 5, 2018
|
By:
|
/s/ Simcha Rock
|
|
|
Simcha Rock
|
|
|
CFO and Director
|
2
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Sep 2023 to Sep 2024